Monograph Details
|
|
Respiratory Tract
> Asthma/COPD
|
|
ALUPENT INHALER |
| Manufacturer |
|
Boehringer Ingelheim Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
β2-agonist. |
| Generic Name |
|
Metaproterenol sulfate 0.65mg/inh; metered dose inhaler. |
| Also |
• ALUPENT INH SOLN VIALS
• Metaproterenol Inh Soln
|
| Indications |
|
Asthma. Bronchospasm. |
| Children |
|
Not recommended. |
| Adults |
|
2–3 inh every 3–4 hrs; max 12 inh daily. |
| Contraindications |
|
Arrhythmias associated with tachycardia. |
| Precautions |
|
Avoid excessive use. Hypertension. Cardiovascular disease. CHF. Hyperthyroidism. Diabetes. Seizure disorders. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Avoid other aerosol β-agonists. Potentiated by sympathomimetics, tricyclics, MAOIs. |
| Adverse Reactions |
|
Tachycardia, nervousness, tremor, headache, dizziness, GI upset, hypertension, paradoxical bronchospasm, cough, bad taste. |
| How Supplied |
Inhaler—7g (100 inh), 14g (200 inh)
Inh soln (2.5mL vials)—25
Inh soln (bottles w. dropper)—contact supplier. |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
